Results 241 to 250 of about 30,760,761 (278)

Overcoming a T-ALL order: A comprehensive study linking genomics to clinical outcomes. [PDF]

Hemasphere
Huang Y, de Bock CE.
europepmc   +1 more source

scRNA-seq reveals an immune microenvironment and JUN-mediated NK cell exhaustion in relapsed T-ALL. [PDF]

Cell Rep Med
Liu Y, Du Z, Li L, Huang J, Liu S, Lu B, Duan Y, Cheng Y, Li T, Zhang J, Mo J, Yang Y, Wang W, Zou H, Liang T, Jiang M, Yang M, Chen Y, Ouyang C, Chen C.   +19 more
europepmc   +1 more source

<i>USP20</i> as a super-enhancer-regulated gene drives T-ALL progression <i>via</i> HIF1A deubiquitination. [PDF]

Acta Pharm Sin B
Xu L, Zhang Z, Yu J, Ji T, Cheng J, Fei X, Chu X, Tao Y, Xu Y, Yang P, Liu W, Li G, Zhang Y, Li Y, Zhang F, Yang Y, Zhou B, Wu Y, Wei Z, Chen Y, Wang J, Wu D, Li X, Yang Y, Qian G, Yin H, Wu S, Zhang S, Liu D, Fan JJ, Shi L, Wang X, Hu S, Lu J, Pan J.   +34 more
europepmc   +1 more source

Single-Cell Multiomics Reveals TCR Clonotype-Specific Phenotype and Stemness Heterogeneity of T-ALL Cells. [PDF]

Cell Prolif
Sui S, Wei X, Zhu Y, Feng Q, Zha X, Mao L, Huang B, Lei W, Chen G, Zhan H, Chen H, Feng R, Zeng C, Li Y, Luo OJ.   +14 more
europepmc   +1 more source

Subclonal TP53 and KRAS variants combined with poor treatment response identify ultrahigh-risk pediatric patients with T-ALL. [PDF]

Blood Adv
Kempter T, Richter-Pechańska P, Michel K, Rausch T, Erarslan-Uysal B, Eckert C, Zimmermann M, Stanulla M, Schrappe M, Cario G, Köhrer S, Attarbaschi A, Korbel JO, Kunz JB, Kulozik AE.   +14 more
europepmc   +1 more source

STAT1-mediated interferon signatures are associated with preclinical JAK inhibitor sensitivity in T-ALL.

Blood
Xu J, Sussman JH, Yang A, Yoshimura S, Hu J, Chen C, Vincent T, Bandyopadhyay S, Li EY, Lim T, Elghawy O, Barsouk A, Karanfilovski D, Wald SL, Chen GM, Wu D, Newman H, Li A, Sun Y, Chen CH, Bernt K, Wood BL, Winter SS, Dunsmore KP, Raetz E, Devidas M, Pounds S, Loh M, Hunger SP, Chiang MY, Diorio C, Di Giacomo D, Pölönen P, Mullighan CG, Yang JJ, Tan K, Teachey DT.   +36 more
europepmc   +1 more source

ATP citrate lyase is an essential player in the metabolic rewiring induced by PTEN loss during T-ALL development. [PDF]

Blood Adv
Andrieu GP, Hypolite G, Latiri M, Balducci E, Costa C, Verhoeyen E, Courgeon M, Allatif O, Nemazanyy I, Panasyuk G, Wellen K, Herranz D, Genestier L, Macintyre E, Asnafi V, Tesio M.   +15 more
europepmc   +1 more source

Tumor-associated myeloid cells support murine T-ALL in the central nervous system via integrin signaling. [PDF]

Blood Neoplasia
Humphrey RS, Nam S, Wylie DC, Ehrlich LIR.   +3 more
europepmc   +1 more source

BIRC5 upregulation enhances DNMT3A-mutant T-ALL cell survival and pathogenesis. [PDF]

Blood Neoplasia
Dunuwille W, Wilson WC, Bjeije H, Issa N, Han W, Parsons TM, Young AL, Xavier Raj I, Krishnan A, Gaur T, Wang ES, Weng AP, Stubbs MC, Celik H, Cashen AF, Edwards JR, Challen GA.   +16 more
europepmc   +1 more source